Page 5 - Demo

GE Digital Breast Tomosynthesis is leading the way when it comes
to breast cancer detection.
DETECT 90% MORE BREAST CANCER􏰕1
A new European two arm test-and-treat randomized trial compares DM+DBT versus DM in screening.
The study concludes that Tomosynthesis plus Digital Mammography detects 90% more cancers than Digital Mammography alone, with similar recall rate. 􏰀􏰁􏰂􏰃 􏰁􏰂􏰅􏰁􏰆􏰇 􏰈􏰆􏰉􏰆􏰊􏰉􏰂􏰋􏰌 􏰍􏰎􏰏 􏰁􏰎􏰐􏰆 􏰎 􏰑􏰆􏰌􏰆􏰒􏰊􏰂􏰎􏰓 􏰂􏰍􏰔􏰎􏰊􏰉 􏰋􏰌 􏰊􏰎􏰌􏰊􏰆􏰇 􏰔􏰇􏰋􏰅􏰌􏰋􏰃􏰂􏰃􏰕
What if you could help improve breast cancer detection? TODAY IT’S POSSIBLE
Senographe PristinaTM Discover the GE DIFFERENCE
• Unparalleled Tube Technology & Rhodium Targets
• Optimized acquisition angle of 25°
• Step & Shoot Acquisition for Blur Reduction
• No Binning Technology
• Universal Grid (2D, 3D)
• ASIR Reconstruction Algorithm
• Detector Technology with high DQE
© 2018 General Electric Company.
GE, the GE Monogram, Senographe Pristina are trademarks of General Electric Company.
Join us in reshaping the mammography experience and 􏰍􏰎􏰖􏰆 􏰎 􏰈􏰂􏰗􏰆􏰇􏰆􏰌􏰊􏰆 􏰘􏰁􏰆􏰌 􏰂􏰉 􏰊􏰋􏰍􏰆􏰃 􏰉􏰋 􏰑􏰇􏰆􏰎􏰃􏰉 􏰊􏰎􏰌􏰊􏰆􏰇 􏰈􏰆􏰉􏰆􏰊􏰉􏰂􏰋􏰌􏰕
#ThePristinaMovement
90%
INCREASE
Breast Cancer Detection
~70%
INCREASE
Detection in Dense Breasts (BI-RADS C&D)
94%
INCREASE
Small Invasive Cancer Detection (<10mm)
􏰙􏰋􏰇 􏰍􏰋􏰇􏰆 􏰈􏰆􏰉􏰎􏰂􏰓􏰃 􏰎􏰑􏰋􏰚􏰉 􏰉􏰁􏰆 􏰃􏰉􏰚􏰈􏰏􏰛 􏰐􏰂􏰃􏰂􏰉􏰜 􏰅􏰆􏰁􏰆􏰎􏰓􏰉􏰁􏰊􏰎􏰇􏰆􏰕􏰊􏰋􏰕􏰚􏰖􏰝􏰍􏰎􏰍􏰍􏰋􏰅􏰇􏰎􏰔􏰁􏰏
1. Digital Mammography versus Digital Mammography plus tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial. https://doi.org/10.1148/radiol.2018172119